Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2022 Oct 27

PMID 36289761

Authors

Shinji Takai

Denan Jin

Affiliations

Soon will be listed here.

Abstract

Chymase present in mast cells can directly form matrix metalloproteinase (MMP)-9 from proMMP-9. Chymase-activated MMP-9 has been reportedly closely related to the pathogenesis of various diseases, and inflammation-related diseases in particular. Upregulated chymase and MMP-9 have been observed in tissues from patients and animal models of aortic aneurysm, inflammatory gastrointestinal and hepatic diseases, acute pancreatic failure, atopic dermatitis and rheumatoid arthritis. Chymase at these regions is only derived from mast cells, while MMP-9 is derived from macrophages and neutrophils in addition to mast cells. Chymase inhibitors attenuate MMP-9 formation from pro-MMP-9, and ameliorate the development and progression of these disorders, along with reduction in inflammatory cell numbers. MMP-9 activated by chymase might also be involved in angiogenesis in the tumor environment. Development of angiogenesis around several cancers is closely related to the expression of chymase and MMP-9, and postoperative survival curves have revealed that patients with a higher number of chymase positive cells have lower survival rates. In this review, we wanted to clarify the role of chymase-activated MMP-9, which might become an important therapeutic target for various inflammatory disorders.

Citing Articles

Exploring the potential mechanism of B-phycoerythrin on DSS-induced colitis and colitis-associated bone loss based on network pharmacology, molecular docking, and experimental validation.

Deng L, Feng Z, Li X, Fan L, Wu X, Tavakoli S Sci Rep. 2025; 15(1):5455.

PMID: 39953092 PMC: 11828949. DOI: 10.1038/s41598-025-90011-5.

Renal Mast Cell-Specific Proteases in the Pathogenesis of Tubulointerstitial Fibrosis.

Atiakshin D, Morozov S, Dlin V, Kostin A, Volodkin A, Ignatyuk M J Histochem Cytochem. 2024; 72(8-9):495-515.

PMID: 39263893 PMC: 11529666. DOI: 10.1369/00221554241274878.

From molecular subgroups to molecular targeted therapy in rheumatoid arthritis: A bioinformatics approach.

Xu Y, Yang Z, Wang T, Hu L, Jiao S, Zhou J Heliyon. 2024; 10(16):e35774.

PMID: 39220908 PMC: 11365346. DOI: 10.1016/j.heliyon.2024.e35774.

Mast Cell Involvement in the Pathogenesis of Selected Musculoskeletal Diseases.

Gutowski L, Kanikowski S, Formanowicz D Life (Basel). 2023; 13(8).

PMID: 37629547 PMC: 10455104. DOI: 10.3390/life13081690.

Unraveling the Links between Chronic Inflammation, Autoimmunity, and Spontaneous Cervicocranial Arterial Dissection.

Li H, Xu S, Xu B, Zhang Y, Yin J, Yang Y J Clin Med. 2023; 12(15).

PMID: 37568534 PMC: 10419694. DOI: 10.3390/jcm12155132.

References

Jin D, Takai S, Nonaka Y, Yamazaki S, Fujiwara M, Nakamura Y . A Chymase Inhibitory RNA Aptamer Improves Cardiac Function and Survival after Myocardial Infarction. Mol Ther Nucleic Acids. 2018; 14:41-51. PMC: 6298900. DOI: 10.1016/j.omtn.2018.11.001. View

Sammarco G, Varricchi G, Ferraro V, Ammendola M, De Fazio M, Altomare D . Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer. Int J Mol Sci. 2019; 20(9). PMC: 6540185. DOI: 10.3390/ijms20092106. View

Deryugina E, Zajac E, Juncker-Jensen A, Kupriyanova T, Welter L, Quigley J . Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment. Neoplasia. 2014; 16(10):771-88. PMC: 4212255. DOI: 10.1016/j.neo.2014.08.013. View

Baugh M, Perry M, Hollander A, Davies D, Cross S, Lobo A . Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology. 1999; 117(4):814-22. DOI: 10.1016/s0016-5085(99)70339-2. View

Badertscher K, Bronnimann M, Karlen S, Braathen L, Yawalkar N . Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch Dermatol Res. 2005; 296(10):503-6. DOI: 10.1007/s00403-005-0542-3. View

Laface C, Laforgia M, Zito A, Loisi D, Zizzo N, Tamma R . Chymase-positive Mast cells correlate with tumor angiogenesis: first report in pancreatic cancer patients. Eur Rev Med Pharmacol Sci. 2021; 25(22):6862-6873. DOI: 10.26355/eurrev_202111_27234. View

Furubayashi K, Takai S, Jin D, Muramatsu M, Ibaraki T, Nishimoto M . The significance of chymase in the progression of abdominal aortic aneurysms in dogs. Hypertens Res. 2007; 30(4):349-57. DOI: 10.1291/hypres.30.349. View

Takai S, Shiota N, Yamamoto D, Okunishi H, Miyazaki M . Purification and characterization of angiotensin II-generating chymase from hamster cheek pouch. Life Sci. 1996; 58(7):591-7. DOI: 10.1016/0024-3205(95)02328-3. View

Tiniakos D, Vos M, Brunt E . Nonalcoholic fatty liver disease: pathology and pathogenesis. Annu Rev Pathol. 2010; 5:145-71. DOI: 10.1146/annurev-pathol-121808-102132. View

10.

Kanemitsu H, Takai S, Tsuneyoshi H, Nishina T, Yoshikawa K, Miyazaki M . Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats. Hypertens Res. 2006; 29(1):57-64. DOI: 10.1291/hypres.29.57. View

11.

Georgescu E, Ionescu R, Niculescu M, Mogoanta L, Vancica L . Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis. World J Gastroenterol. 2009; 15(8):942-54. PMC: 2653406. DOI: 10.3748/wjg.15.942. View

12.

De Young M, Nemeth E, Scarpa A . Measurement of the internal pH of mast cell granules using microvolumetric fluorescence and isotopic techniques. Arch Biochem Biophys. 1987; 254(1):222-33. DOI: 10.1016/0003-9861(87)90098-1. View

13.

Lee J, Jeon Y, Xin M, Lim J, Lee Y, Kim D . Mast cell modulates tumorigenesis caused by repeated bowel inflammation condition in azoxymethane/dextran sodium sulfate-induced colon cancer mouse model. Biochem Biophys Rep. 2022; 30:101253. PMC: 8976097. DOI: 10.1016/j.bbrep.2022.101253. View

14.

Yan C, Zhou L, Han Y . Contribution of hepatic stellate cells and matrix metalloproteinase 9 in acute liver failure. Liver Int. 2008; 28(7):959-71. DOI: 10.1111/j.1478-3231.2008.01775.x. View

15.

Katada J, Muramatsu M, Hayashi I, Tsutsumi M, Konishi Y, Majima M . Significance of vascular endothelial cell growth factor up-regulation mediated via a chymase-angiotensin-dependent pathway during angiogenesis in hamster sponge granulomas. J Pharmacol Exp Ther. 2002; 302(3):949-56. DOI: 10.1124/jpet.102.034231. View

16.

Fang K, Raymond W, Blount J, Caughey G . Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem. 1997; 272(41):25628-35. DOI: 10.1074/jbc.272.41.25628. View

17.

Oyamada S, Bianchi C, Takai S, Chu L, Sellke F . Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion. J Pharmacol Exp Ther. 2011; 339(1):143-51. PMC: 11047277. DOI: 10.1124/jpet.111.179697. View

18.

Kuramoto T, Jin D, Komeda K, Taniguchi K, Hirokawa F, Takai S . Chymase as a Novel Therapeutic Target in Acute Pancreatitis. Int J Mol Sci. 2021; 22(22). PMC: 8621078. DOI: 10.3390/ijms222212313. View

19.

Miyaoka Y, Jin D, Tashiro K, Komeda K, Masubuchi S, Hirokawa F . Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet. J Pharmacol Sci. 2017; 134(3):139-146. DOI: 10.1016/j.jphs.2017.04.005. View

20.

Decker K, Keppler D . Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev Physiol Biochem Pharmacol. 1974; (71):77-106. DOI: 10.1007/BFb0027661. View